AMGEN has announced it will cut
2,400 to 2,900 jobs starting later
this year and continuing to next
year, mostly in the US.
This was 12 to 15% of its global
workforce, Amgen said.
The company made the
announcement as part of its
second quarter results, which also
reported that revenue were up
11% to US$5.2b, with 8% product
sales growth driven by sales of
Enbrel (entanercept) and Kyprolis
(cafilzomib).
CLICK HERE for more.The above article was sent to subscribers in Pharmacy Daily's issue from 31 Jul 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 31 Jul 14
PEAK pharmacy bodies are calling on the Australian Government to extend the new Commonwealth Prac Payment to pharmacy students, citing the challenges of “placement poverty” in unpaid practical placements.
AFT Pharmaceuticals is set to develop a topical treatment for keloid and hypertrophic scarring in partnership with NZ’s Massey Ventures, the commercialisation arm of Massey University, and the Gillies McIndoe Research Institute.
THE Pharmaceutical Society of Australia (PSA) awarded Brooke Shelly the prestigious 2024 PSA MIMS Credentialed Pharmacist of the Year award last Fri at the Credentialed Pharmacist Conference (CPC24) (PD breaking news).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.